{"version":"1.0","provider_name":"Neuraxpharm Belgique","provider_url":"https:\/\/www.neuraxpharm.com\/be-fr","author_name":"Jaime Fern\u00e1ndez","author_url":"https:\/\/www.neuraxpharm.com\/be-fr\/blog\/auteur\/jaime","title":"CHARLES MORRIS","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"L2e0NOWu9n\"><a href=\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/charles-morris-2\">CHARLES MORRIS<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.neuraxpharm.com\/be-fr\/a-propos-de-nous\/comite-executif\/charles-morris-2\/embed#?secret=L2e0NOWu9n\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0CHARLES MORRIS\u00a0\u00bb &#8212; Neuraxpharm Belgique\" data-secret=\"L2e0NOWu9n\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.neuraxpharm.com\/be-fr\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"https:\/\/www.linkedin.com\/in\/ana-apezteguia-moragas\/ Neuraxpharm CHARLES MORRIS Charles Morris a rejoint Neuraxpharm en tant que Head of Mergers &amp; Acquisitions en janvier 2022. Charles est un professionnel chevronn\u00e9 des fusions et acquisitions, avec 20 ans d\u2019exp\u00e9rience en banque d\u2019investissement et en fusions et acquisitions d\u2019entreprises dans l\u2019industrie pharmaceutique, dans plusieurs r\u00e9gions du monde, notamment aux \u00c9tats-Unis, en Allemagne [&hellip;]","thumbnail_url":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-content\/uploads\/sites\/31\/2023\/03\/charles-morris.jpg"}